carbamates has been researched along with fluorides in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (75.86) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 3 (10.34) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, MK | 2 |
| Kamal, A | 1 |
| Bieth, J; Cooper, AG; Erlanger, BF; Vratsanos, SM; Wassermann, NH | 1 |
| Becker, CE | 1 |
| Erlanger, BF; Sack, RA | 1 |
| Greenspan, CM; Wilson, IB | 1 |
| Harwood, JL; Stumpf, PK | 1 |
| Beacham, LM; Hiskey, RG; Matl, VG; Smith, JN; Thomas, AM; Williams, EB; Wolters, ET | 1 |
| Baker, BR; Lourens, GJ | 1 |
| Baker, BR; Meyer, RB | 2 |
| Baker, BR; Erickson, EH | 1 |
| Baker, BR; Lourens, GJ; Meyer, RB; Vermeulen, NM | 1 |
| Baker, BR; Vermeulen, NM | 4 |
| Dastoli, FR; Musto, NA; Price, S | 1 |
| Maki, T; Matsumura, Y; Onomura, O; Satoh, Y | 1 |
| METZGER, HP; WILSON, IB | 2 |
| DAVIES, R; SZABO, G | 1 |
| BRZOZOWSKI, T; DUFFIELD, PH; KALMAN, SM | 1 |
| El Kharbili, M; Fekonja, O; Fournier, D; Stojan, J; Zorec-Karlovsek, M | 1 |
| Ito, N; Kimura, T; Kiso, Y; Yoshiya, T | 1 |
| Adibekian, A; Bachovchin, DA; Blankman, JL; Cravatt, BF; Hoover, H; Ji, T; Li, W; Niessen, S; Simon, GM | 1 |
| Amano, M; Das, D; Ghosh, AK; Mitsuya, H; Mizuno, A; Salcedo Gómez, PM; Yashchuk, S | 1 |
| Bouayad-Gervais, S; Scattolin, T; Schoenebeck, F | 1 |
1 review(s) available for carbamates and fluorides
| Article | Year |
|---|---|
Organophosphorus esters causing delayed neurotoxic effects: mechanism of action and structure activity studies.
Topics: Animals; Ataxia; Binding Sites; Carbamates; Chickens; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Esterases; Fluorides; Humans; Nervous System; Organophosphates; Organophosphonates; Organophosphorus Compounds; Organothiophosphorus Compounds; Phosphinic Acids; Structure-Activity Relationship; Tritolyl Phosphates | 1975 |
28 other study(ies) available for carbamates and fluorides
| Article | Year |
|---|---|
Metabolism of ethyl 2-carbamoyloxybenzoate (4003/2), a prodrug of salicylic acid, carsalam and salicylamide.
Topics: Animals; Carbamates; Chromatography, High Pressure Liquid; Fluorides; Male; Mitochondria, Liver; Oxazines; Potassium; Potassium Compounds; Prodrugs; Rats; Salicylamides; Salicylates; Salicylic Acid | 1990 |
Photoregulation of biological activity by photochromic reagents. Inactivators of acetylcholinesterase.
Topics: Acetylcholinesterase; Aniline Compounds; Animals; Azo Compounds; Carbamates; Chlorides; Cholinesterase Inhibitors; Electric Organ; Fishes; Fluorides; Isomerism; Kinetics; Mathematics; Models, Structural; Molecular Conformation; Photochemistry; Spectrophotometry, Ultraviolet; Time Factors | 1973 |
Screening of 563 students for cholinesterase variants.
Topics: Benzyl Compounds; Carbamates; Cholinesterase Inhibitors; Cholinesterases; Cyclohexanes; Dibucaine; Female; Fluorides; Genetics, Medical; Heterozygote; Homozygote; Humans; Isoenzymes; Male; Phenols; Piperidines; Quaternary Ammonium Compounds | 1972 |
Opertional normality of alpha-chymotrypsin solutions by a sensitive potentiometric technique using a fluoride electrode.
Topics: Carbamates; Chymotrypsin; Conductometry; Electrodes; Fluorides; Methods | 1970 |
The effect of fluoride on the reaction of acetylcholinesterase with carbamates.
Topics: Acetylcholinesterase; Buffers; Carbachol; Carbamates; Chemical Phenomena; Chemistry; Choline; Fluorides; Hydroxylamines; Phosphates; Sodium | 1970 |
Organophosphorus and other inhibitors of brain 'neurotoxic esterase' and the development of delayed neurotoxicity in hens.
Topics: Animals; Ataxia; Binding Sites; Brain; Carbamates; Chickens; Cholinesterase Inhibitors; Esterases; Esters; Female; Fluorides; Insecticides; Nervous System Diseases; Phosphoric Acids; Time Factors | 1970 |
Fat metabolism in higher plants. 43. Control of fatty acid synthesis in germinating seeds.
Topics: Acetates; Arsenic; Carbamates; Carbon Isotopes; Fatty Acids; Fluorides; Herbicides; Linoleic Acids; Lipids; Palmitic Acids; Plants; Seeds; Stearic Acids; Succinates; Sulfonic Acids; Temperature | 1971 |
Sulfur-containing polypeptides. XIV. Removal of the tert-butyloxycarbonyl group with boron trifluoride etherate.
Topics: Boron; Butyrates; Carbamates; Chemical Phenomena; Chemistry; Cysteine; Ethers; Fluorides; Peptides | 1971 |
Irreversible enzyme inhibitors. CXLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[p-(p-fluorosulfonylphenylureidomethyl)phenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Spleen; Sulfonic Acids; Triazines | 1969 |
Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Pyrimidines; Spleen; Sulfonic Acids | 1969 |
Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Culture Techniques; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Pyrimidines; Spleen; Sulfonic Acids | 1969 |
Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.
Topics: Amidines; Anilides; Arginine; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Ethers; Fluorides; Sulfonic Acids; Thrombin; Trypsin Inhibitors | 1969 |
Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Chlorine; Depression, Chemical; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Pyrimidines; Spleen; Sulfonic Acids; Tetrahydrofolate Dehydrogenase; Time Factors; Triazines | 1969 |
Irreversible enzyme inhibitors. CXXXIV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonyl-phenylureido)phenoxymet
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Chlorine; Fluorides; Folic Acid Antagonists; Leukemia L1210; Liver; Methylation; Mice; Pyrimidines; Sulfonic Acids; Time Factors | 1969 |
Irreversible enzyme inhibitors. CXXXVI. 2,4-Diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenzamido)phenoxymethyl]pyrimidine, an active-site-directed irreversible inhibitor of dihydrofolic reductase. Effect of structure on isozyme specificity.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chlorine; Fluorides; Folic Acid Antagonists; Intestines; Isoenzymes; Leukemia L1210; Liver; Mice; Pyrimidines; Spleen; Sulfonic Acids | 1969 |
Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Chlorine; Fluorides; Folic Acid Antagonists; Isoenzymes; Leukemia L1210; Liver; Mice; Pyrimidines; Sulfonic Acids | 1969 |
Irreversible enzyme inhibitors. CXXXVI. 2,4-Diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenz amido) phenoxymethyl] pyrimidine, an active-site-directed irreverisible inhibitor of dihydrofolic reductase. Effect of structure on isozyme specificity.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chlorine; Fluorides; Folic Acid Antagonists; Intestines; Isoenzymes; Leukemia L1210; Liver; Mice; Pyrimidines; Spleen; Sulfonic Acids | 1969 |
Reactivity of active sites of chymotrypsin suspended in an organic medium.
Topics: Carbamates; Catalysis; Chemical Phenomena; Chemistry; Chromatography, Paper; Chymotrypsin; Fluorides; Hydrocarbons, Halogenated; Nitrobenzenes; Solutions | 1966 |
A new method for synthesis of unsymmetrical ureas using electrochemically prepared trifluoroethyl carbamates.
Topics: Amines; Carbamates; Electrochemistry; Fluorides; Formic Acid Esters; Magnetic Resonance Spectroscopy; Urea | 2000 |
ACCELERATION OF THE RATE OF REACTION OF DIMETHYLCARBAMYL FLUORIDE AND ACETYLCHOLINESTERASE BY SUBSTITUTED AMMONIUM IONS.
Topics: Acetylcholinesterase; Ammonium Compounds; Carbamates; Chemical Phenomena; Chemistry; Esters; Fluorides; Quaternary Ammonium Compounds; Research; Tetraethylammonium Compounds | 1963 |
EVIDENCE FOR AN ELECTROPHILIC MECHANISM IN CATALYSIS BY HYDROLYTIC ENZYMES.
Topics: Acetylcholinesterase; Ammonium Compounds; Carbamates; Catalysis; Chlorides; Cholinesterase Inhibitors; Chymotrypsin; Enzyme Inhibitors; Ethylamines; Fluorides; Hydrolysis; Indoles; Quaternary Ammonium Compounds; Research; Tetraethylammonium Compounds; Trypsin Inhibitors | 1964 |
STUDIES ON THE BETA-GALACTOSIDASE ACTIVITY OF SACCHAROMYCES FRAGILIS.
Topics: Azides; beta-Galactosidase; Carbamates; Chlorides; Citrates; Dinitrophenols; Diphosphates; Edetic Acid; Fluorides; Galactosidases; Metabolism; Oximes; Pharmacology; Potassium; Research; Saccharomyces; Sulfates; Sulfides | 1964 |
IDENTITY IN ESCHERICHIA COLI OF CARBAMYL PHOSPHOKINASE AND AN ACTIVITY WHICH CATALYZES AMINO GROUP TRANSFER FROM GLUTAMINE TO ORNITHINE IN CITRULLINE SYNTHESIS.
Topics: Amino Acids; Azaserine; Biochemical Phenomena; Biochemistry; Carbamates; Chromatography; Citrulline; Electrophoresis; Escherichia coli; Fluorides; Glutamine; Ketoglutaric Acids; Ornithine; Pharmacology; Phosphotransferases; Phosphotransferases (Carboxyl Group Acceptor); Research; Sulfhydryl Compounds | 1965 |
Inhibition and protection of cholinesterases by methanol and ethanol.
Topics: Alcohols; Animals; Carbamates; Chemistry; Cholinesterase Inhibitors; Cholinesterases; Ethanol; Fluorides; Horses; Kinetics; Methanol; Models, Chemical; Phosphates; Phosphorylation; Physostigmine; Substrate Specificity | 2007 |
Isopeptide method: development of S-acyl isopeptide method for the synthesis of difficult sequence-containing peptides.
Topics: Amino Acid Sequence; Carbamates; Chemistry; Chromatography, High Pressure Liquid; Cysteine; Fluorides; Hydrogen-Ion Concentration; Models, Chemical; Molecular Sequence Data; Molecular Structure; Peptide Fragments; Peptides; Solubility | 2008 |
Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening.
Topics: Carbamates; Catalytic Domain; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fluorides; Humans; Hydrolases; Molecular Probes; Phosphates; Protein Binding; Proteome; Serine; Small Molecule Libraries; Substrate Specificity | 2010 |
GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.
Topics: Animals; Astrocytes; Atazanavir Sulfate; Blood-Brain Barrier; Carbamates; Cell Line; Darunavir; Drug Resistance, Multiple, Viral; Endothelial Cells; Fluorides; Haplorhini; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Lopinavir; Models, Biological; Molecular Docking Simulation; Oligopeptides; Pericytes; Pyridines; Rats; Saquinavir; Sulfonamides; T-Lymphocytes; Virus Replication | 2013 |
Straightforward access to N-trifluoromethyl amides, carbamates, thiocarbamates and ureas.
Topics: Amides; Carbamates; Fluorides; Isothiocyanates; Pharmaceutical Preparations; Urea | 2019 |